Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Intellipharmaceutics International Inc.

TRADE

NASDAQ: IPCIHealthcare / Drug Delivery / Canada
0.52+0.03+6.12%Vol 52 7171Y Perf -94.24%
Nov 21st, 2018 10:11
BID0.52 ASK0.53
Open0.56 Previous Close0.50
Pre-Market0.55 After-Trading0.49
 0.05 10.00%  -0.01 -2.00%
Target Price
27.50 
Analyst Rating
Moderate Buy 2.33
Potencial %
5 188.46 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
★+     41.56
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)2 
Earnings Rating
Neutral
Price Range Ratio 52wk %
0.60 
Earnings Date
27th Nov 2018

Today's Price Range

0.500.56

 

52wk Range

0.4610.50

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Month
-20.97%
3 Months
88.46%
6 Months
13.95%
1 Year
-94.24%
3 Years
-73.94%
5 Years
-87.63%

Quotes

Name / TickerPriceChg.Chg.%
IPCI0.520.03006.12
AAPL177.960.98000.55
GOOG1 043.1517.39001.70
MSFT103.391.68001.65
XOM77.580.61000.79
WFC52.940.40000.76
JNJ143.00-3.4500-2.36
FB136.193.76002.84
GE7.830.18002.35
JPM109.060.61000.56
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 0.10
Current Ratio 0.20
Long Term Debt to Total Capital -
Total Debt to Equity 3.34
Interest Coverage -31.30
Leverage Ratio -3.00
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin90.50
EBIT Margin-503.10
EBITDA Margin-476.60
Pre-tax Profit Margin-318.10
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 62.79
PS Ratios 1.07
Price to Cash Flow -
Price to Free Cash Flow -0.40
Cash Flow Per Share -2.92
Price to Tangible Book-0.63
Book Value per Share-0.70
Enterprise Value (in ths.)4 365
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)445 241.00
ROE last 12 Months 436.35
Return on Assets (5Y Avg) -131.80
ROA last 12 Months -207.83
Return on Capital (5Y Avg) -
ROC last 12 Months -189.03
Return on invested Capital Q -189.03
Return on invested Capital Y-387.94
Assets Turnover0.40
Receivables Turnover2.20
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)2 321
Revenue per Share 0.45
Revenue Growth 3 Years -7.46
Revenue Growth 5 Years 53.66
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018-0.70-0.700.00
Q01 2018-0.50-0.90-80.00
Q04 2017-0.70-0.80-14.29
Q03 2017-0.40-0.80-100.00
Q02 2017-0.50-0.60-20.00
Q01 2017-0.08-0.0712.50
Q04 2016-0.06-0.14-133.33
Q03 2016-0.07-0.070.00
Earnings Per EndEstimateRevision %Trend
8/2018 QR-0.400.00-
11/2018 QR0.00--
11/2018 FY-1.950.00-
11/2019 FY-1.000.00-
Next Report Date27th Nov 2018
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume52 717
Shares Outstanding (in ths.)4 350
Trades Count41
Dollar Volume24 437
Avg. Volume107 706
Avg. Weekly Volume107 556
Avg. Monthly Volume331 124
Avg. Quarterly Volume307 548

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

50%50%

Bearish Bullish

41%59%

Bearish Bullish

76%24%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (33.33 %)
2 (66.67 %)
2 (66.67 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
2 (66.67 %)
1 (33.33 %)
1 (33.33 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
2.33
Moderate Buy
1.67
Moderate Buy
1.67

There are no comments yet.

News

x